Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease

• Javier de Miguel Díez ^[1] ; Julio Núñez Villota ^[2] ; Salud Santos Pérez ^[6] ; Nicolás Manito Lorite ^[7] ; Bernardino Alcázar Navarrete ^[3] ; Juan Francisco Delgado Jiménez ^[4] ; Juan José Soler Cataluña ^[8] ; Domingo Pascual Figal ^[9] ; Patricia Sobradillo Ecenarro ^[10] ; Juan José Gómez Doblas ^[5]
  1. [1] Hospital General Universitario Gregorio Marañón

     Hospital General Universitario Gregorio Marañón

     Madrid, España

     
  2. [2] Hospital Clinico Universitario de Valencia

     Hospital Clinico Universitario de Valencia

     Valencia, España

     
  3. [3] Hospital Universitario Virgen de las Nieves

     Hospital Universitario Virgen de las Nieves

     Granada, España

     
  4. [4] Hospital Universitario 12 de Octubre

     Hospital Universitario 12 de Octubre

     Madrid, España

     
  5. [5] Hospital Universitario Virgen de la Victoria

     Hospital Universitario Virgen de la Victoria

     Málaga, España

     
  6. [6] Servicio de Neumología, Hospital Universitario de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain
  7. [7] Unidad de Insuficiencia Cardiaca y Trasplante Cardiaco, Hospital Universitario de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain
  8. [8] Servicio de Neumología, Hospital Arnau de Vilanova-Lliria, Valencia, Spain
  9. [9] Servicio de Cardiología, Hospital Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain
  10. [10] Servicio de Neumología, Hospital Universitario de Cruces, Barakaldo, Bizkaia, Spain

  Mostrar afiliaciones +
• Localización: Archivos de bronconeumología: Organo oficial de la Sociedad Española de Neumología y Cirugía Torácica SEPAR y la Asociación Latinoamericana de Tórax ( ALAT ), ISSN 0300-2896, Vol. 60, Nº. 4, 2024, págs. 226-237
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) frequently coexist, increasing the prevalence of both entities and impacting on symptoms and prognosis. CVD should be suspected in patients with COPD who have high/very high risk scores on validated scales, frequent exacerbations, precordial pain, disproportionate dyspnea, or palpitations. They should be referred to cardiology if they have palpitations of unknown cause or angina pain. COPD should be suspected in patients with CVD if they have recurrent bronchitis, cough and expectoration, or disproportionate dyspnea. They should be referred to a pulmonologist if they have rhonchi or wheezing, air trapping, emphysema, or signs of chronic bronchitis. Treatment of COPD in cardiovascular patients should include long-acting muscarinic receptor antagonists (LAMA) or long-acting beta-agonists (LABA) in low-risk or high-risk non-exacerbators, and LAMA/LABA/inhaled corticosteroids in exacerbators who are not controlled with bronchodilators. Cardioselective beta-blockers should be favored in patients with CVD, the long-term need for amiodarone should be assessed, and antiplatelet drugs should be maintained if indicated.